Monopoly concerns push FTC to sue to block Amgen's more than $26B deal for Horizon
Federal regulators are suing to block biotech drug developer Amgen’s more than $26 billion deal for Horizon Therapeutics
Federal regulators are suing to block biotech drug developer Amgen’s more than $26 billion deal for Horizon Therapeutics
Amgen will acquire Horizon Therapeutics, a biopharmaceutical company that focuses on treatments for rare, autoimmune dis...
Toronto-Dominion Bank is buying regional bank First Horizon in a $13.4 billion all-cash deal that will help broaden its...
Winter is on the horizon again with the end of daylight saving time coming Sunday across most of the United States
Early in 2020, Apple appeared to be caught in a horrible bind
Peugeot maker PSA Group says it has lost 700 million euros in China despite record profits last year